Mechanisms of Action of Troglitazone in the Prevention of High Glucose–Induced Migration and Proliferation of Cultured Coronary Smooth Muscle Cells (Q73944461)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 December 1997

Language	Label	Description	Also known as
English	Mechanisms of Action of Troglitazone in the Prevention of High Glucose–Induced Migration and Proliferation of Cultured Coronary Smooth Muscle Cells	scientific article published on 01 December 1997

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9400375%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Mechanisms of action of troglitazone in the prevention of high glucose-induced migration and proliferation of cultured coronary smooth muscle cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9400375%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Mechanisms of Action of Troglitazone in the Prevention of High Glucose–Induced Migration and Proliferation of Cultured Coronary Smooth Muscle Cells (English)

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

author name string

K. Yasunari

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9400375

28 November 2024

M. Kohno

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9400375

28 November 2024

H. Kano

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9400375

28 November 2024

K. Yokokawa

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9400375

28 November 2024

M. Minami

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9400375

28 November 2024

J. Yoshikawa

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9400375

28 November 2024

language of work or name

0 references

publication date

1 December 1997

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9400375%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

December 1997

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9400375

28 November 2024

full work available at URL

https://www.ahajournals.org/doi/full/10.1161/01.RES.81.6.953

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

Circulation Research

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9400375%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

81

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9400375%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9400375%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

953-962

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9400375%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Incidence and clinical significance of coronary artery disease in diabetes mellitus

1

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

The pathogenesis of atherosclerosis--an update

3

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

Hyperglycemic pseudohypoxia and diabetic complications.

4

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

The new oral hypoglycemic agent, CS-045, inhibits the lipid peroxidation of human plasma low density lipoprotein in vitro

5

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

7

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

Insulin resistance, glucose intolerance, hyperinsulinemia and dyslipidemia in patients with angiographically demonstrated coronary artery disease

8

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

American Journal of Physiology

9

264

F24

publication date

1993

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

American Journal of Physiology

10

267

R628

publication date

1994

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

Glucocorticoids and dopamine-1 receptors on vascular smooth muscle cells.

12

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

Adrenomedullin as a novel antiproliferative factor of vascular smooth muscle cells

13

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat liver

15

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

Phorbol ester and atrial natriuretic peptide receptor response on vascular smooth muscle

17

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia

20

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

Role of oxidative stress in development of complications in diabetes

21

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

Requirement for generation of H2O2 for platelet-derived growth factor signal transduction

22

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation

24

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

In vitro and in vivo reduction of erythrocyte sorbitol by ascorbic acid

25

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications

26

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

Lysophosphatidylcholine increases vascular superoxide anion production via protein kinase C activation.

27

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

Characterization of glucose-induced in situ protein kinase C activity in cultured vascular smooth muscle cells

28

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

Protein kinase C and lipid signaling for sustained cellular responses

29

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

Phosphatidylcholine is a major source of phosphatidic acid and diacylglycerol in angiotensin II-stimulated vascular smooth-muscle cells

30

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat.

31

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

32

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

33

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts

34

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

American Journal of Physiology

35

265

R726

publication date

1993

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

Pathogenesis of NIDDM. A balanced overview

36

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

Banting lecture 1986. Does a common mechanism induce the diverse complications of diabetes?

37

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

Diabetes and atherosclerosis ? The role of insulin

38

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

Effect of glucose, insulin, and insulin-like growth factor-I on glucose transport activity in cultured rat vascular smooth muscle cells

39

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

Prevention by protein kinase C inhibitors of glucose-induced insulin-receptor tyrosine kinase resistance in rat fat cells

40

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

Up-regulation of intracellular signalling pathways may play a central pathogenic role in hypertension, atherogenesis, insulin resistance, and cancer promotion--the 'PKC syndrome'

41

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

Experimental and Clinical Endocrinology

42

81

280

publication date

1983

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta

43

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

Binding and biological effects of insulin, insulin analogues and insulin-like growth factors in rat aortic smooth muscle cells. Comparison of maximal growth promoting activities

44

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

Chronic effects of glucose on insulin signaling in A-10 vascular smooth muscle cells

45

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

46

1 reference

10.1161/01.RES.81.6.953

https://api.crossref.org/works/10.1161/01.RES.81.6.953

28 November 2024

Identifiers

10.1161/01.RES.81.6.953

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9400375%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9400375%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73944461&oldid=2280653073"